Ptc Therapeutics Inc (PTCT)

Jul 23, 2025

PTC Therapeutics Surges to 488th in Daily Rankings with 2.35 Billion Trading Volume Despite Slight Price Decline - AInvest

Jul 23, 2025

Jul 23, 2025

8,196 Shares in PTC Therapeutics, Inc. (NASDAQ:PTCT) Bought by Edgestream Partners L.P. - MarketBeat

Jul 23, 2025

Jul 23, 2025

Huntington's Disease Clinical, Companies, Therapeutic - openPR.com

Jul 23, 2025

Jul 22, 2025

What analysts say about PTC Therapeutics Inc. stockPhenomenal wealth increase - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

PTC Therapeutics Inc. Stock Analysis and ForecastDouble or triple returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Is PTC Therapeutics Inc. a good long term investmentExceptional market positioning - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives PTC Therapeutics Inc. stock priceRobust investment performance - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Cwm LLC Buys 14,139 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jul 22, 2025

Jul 22, 2025

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results - Kilgore News Herald

Jul 22, 2025

Jul 21, 2025

Pega to Announce Financial Results for the Second Quarter of 2025 and Host Conference Call and Webcast - Yahoo.co

Jul 21, 2025

Jul 21, 2025

Pierre Gravier Sells 2,516 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) Stock - MarketBeat

Jul 21, 2025

Jul 20, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

Jul 20, 2025

Jul 19, 2025

William Blair Predicts Weaker Earnings for PTC Therapeutics - MarketBeat

Jul 19, 2025

Jul 18, 2025

William Blair Forecasts Lower Earnings for PTC Therapeutics - MarketBeat

Jul 18, 2025

Jul 17, 2025

What makes PTC Therapeutics Inc. stock price move sharplyFree Premium Stock Market Reports - beatles.ru

Jul 17, 2025

Jul 17, 2025

PTC Therapeutics Advances PKU Treatment with Sepiapterin Study - TipRanks

Jul 17, 2025

Jul 17, 2025

PTC Therapeutics’ Gene Therapy Trial: A Promising Update for Investors - TipRanks

Jul 17, 2025

Jul 17, 2025

Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance - GlobeNewswire Inc.

Jul 17, 2025

Jul 14, 2025

PTC Therapeutics stock gets Buy rating from UBS ahead of FDA decision - Investing.com Canada

Jul 14, 2025

Jul 14, 2025

Allspring Global Investments Holdings LLC Acquires Shares of 10,287 PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jul 14, 2025

Jul 14, 2025

Banque Pictet & Cie SA Acquires New Stake in PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jul 14, 2025

Jul 09, 2025

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Jul 09, 2025

Jul 07, 2025

PTC Therapeutics: Regulatory Catalysts and Financial Fortitude Position the Company for a Breakout Year - AInvest

Jul 07, 2025

Jul 05, 2025

Cantor Fitzgerald Has Negative View of PTCT FY2026 Earnings - MarketBeat

Jul 05, 2025

Jul 04, 2025

PTCT FY2025 EPS Forecast Decreased by Cantor Fitzgerald - MarketBeat

Jul 04, 2025

Jun 30, 2025

PTC Therapeutics Receives 2023 EURORDIS Black Pearl Company Award for Innovation - Seeking Alpha

Jun 30, 2025

Jun 30, 2025

PTC Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating - inkl

Jun 30, 2025

Jun 25, 2025

EC approves PTC Thera’s Sephience for PKU - The Pharma Letter

Jun 25, 2025

Jun 25, 2025

Germany will be first launch for PTC's phenylketonuria drug - pharmaphorum

Jun 25, 2025

Jun 24, 2025

PTCT Investors Have Opportunity to Join PTC Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire

Jun 24, 2025

Jun 23, 2025

Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU) - Yahoo Finance

Jun 23, 2025

Jun 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc.PTCT - PR Newswire

Jun 22, 2025

Jun 21, 2025

PTC Therapeutics upgraded at BofA on FDA review for Friedreich's ataxia drug - MSN

Jun 21, 2025

Jun 20, 2025

Truist Initiates PTC Therapeutics (PTCT) Coverage with Buy Rating on Drug Launches - Yahoo Finance

Jun 20, 2025

Jun 19, 2025

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – Company Announcement - Financial Times

Jun 19, 2025

Jun 18, 2025

10 Biotech Stocks Screaming a Buy - Insider Monkey

Jun 18, 2025

Jun 17, 2025

PTC Therapeutics (PTCT): Truist Securities Initiates Coverage with 'Buy' Rating | PTCT Stock News - GuruFocus

Jun 17, 2025